EGFR and neoplasm: As a downstream regulatory object of EGFR in EGFR-STAT3 oncogenic pathway, aberrantly activated and up-regulated STAT3 signaling pathway has been detected in various cancers including HCC and is considered as an essential risk factor for tumor initiation and development [38–40].